SAN FRANCISCO, May 11, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The CEO will depart following the completion of the sale to ...

Bolt-on Acquisition Accelerates Elanco’s Expansion in Pet Health Differentiated, disruptive portfolio in atopic dermatitis and other chronic unmet needs expected to unlock upside to Elanco’s long-term ...

Ben Ames has spent 30 years as a journalist since starting out as a reporter for daily newspapers in Pennsylvania and Massachusetts. He has focused on business and technology reporting since 1999 for ...